Amitriptyline Antibody (8.F.9): sc-57614

Amitriptyline Antibody (8.F.9) is a mouse monoclonal IgG1 antibody that detects amitriptyline in non-species reactive (NSR) samples through enzyme-linked immunosorbent assay (ELISA). Amitriptyline, a tricyclic compound, plays a crucial role in modulating neurotransmitters, particularly serotonin and noradrenaline, which are vital for mood regulation and emotional stability. By inhibiting the reuptake of these neurotransmitters, amitriptyline effectively alleviates symptoms of various depressive disorders, including endogenous depression and reactive depression, making anti-amitriptyline antibody (8.F.9) an essential tool for therapeutic monitoring in psychiatry. Additionally, amitriptyline′s ability to interact with specific receptors in the central nervous system underscores its importance in treating conditions such as nocturnal enuresis and managing chronic pain. The unique structure of amitriptyline, characterized by its three-ring system, contributes to its pharmacological properties, allowing amitriptyline to penetrate the blood-brain barrier effectively. However, caution is warranted, as overdose can lead to severe side effects, including cardiotoxicity and irreversible neural impairment, highlighting the need for careful dosage and monitoring in clinical settings.